Roth Capital Upgrades Antares Pharma (AIS) to Buy
Tweet
Share
E-mailGet Alerts AIS Hot Sheet
Price: $77.61 +1.93%
Rating Summary:
3 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 15 | New: 50
Rating Summary:
3 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 15 | New: 50
Join SI Premium – FREE
Roth Capital upgraded Antares Pharma (NYSE: AIS) from Neutral to Buy, price target raised from $2 to $3.50.
For an analyst ratings summary and ratings history on Antares Pharma click here. For more ratings news on Antares Pharma click here.
Shares of Antares Pharma closed at $2.56 yesterday.
For an analyst ratings summary and ratings history on Antares Pharma click here. For more ratings news on Antares Pharma click here.
Shares of Antares Pharma closed at $2.56 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Macquarie Upgrades Merdeka Gold Resources (EMAS:IJ) to Neutral
- JPMorgan Upgrades Sandfire Resources NL (SFR:AU) (SNDFY) to Overweight
- Piper Sandler Upgrades Alerus Financial Corp. (ALRS) to Overweight
Create E-mail Alert Related Categories
UpgradesRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
